LughaEnglishFrançaisالعربيةEspañolPortuguêsРусскийУкраїнськаTürkçeفارسیاردوবাংলাहिन्दीKiswahiliአማርኛनेपालीසිංහලSrpskiO'zbekchaМонгол

Wolters Kluwer (Lippincott)

A major medical publisher without a standalone country-based waiver. Authors in low-income countries without an institutional Read & Publish agreement pay the full APC. This is a critical gap: an author in Ethiopia publishing in a Lippincott OA journal pays full price unless their institution has an R&P deal.

Sera za wachapishaji zimekaguliwa 20 August 2026

ClassificationResearch4Life eligibility criteria
Scale200+ medical journals (Lippincott brand), predominantly hybrid
APC range$1,050–$3,950
Which author countsCorresponding author at participating institution
HybridNot stated
How it is appliedInstitutional R&P agreements only; no standalone country-based waiver published

Hii inamaanisha nini kwa waandishi

A major medical publisher without a standalone country-based waiver. Authors in low-income countries without an institutional Read & Publish agreement pay the full APC. This is a critical gap: an author in Ethiopia publishing in a Lippincott OA journal pays full price unless their institution has an R&P deal.

Angalia nchi yako

Je, unastahili msamaha au punguzo la ada? Weka nchi yako kuona wachapishaji wanaotoa APC zilizopunguzwa.

MISAMAHA KWA NCHI →

Vyanzo vya ukurasa huu

Sera
Wolters Kluwer (Lippincott) — waiver / APC policy
Alt
Wolters Kluwer (Lippincott) — additional policy page
imekaguliwa
20 August 2026